Revealing Cancer's Genetic Secrets through Nucleic Acid Purification with MACHEREY-NAGEL

Unlocking Tomorrow’s Oncology: Precision Chemistry for Next-Generation Cancer Research

The field of cancer research has undergone a fundamental transformation. We have transitioned from broad, one-size-fits-all treatments to an era of absolute subcellular precision.

Today’s leading oncologists don't just study tumors. They map them at single-cell, spatial, and epigenetic resolutions. However, your cutting-edge sequencing data is only as good as the nucleic acids you input.

At Macherey-Nagel, we develop pure extraction and library preparation chemistries that bridge the gap between complex laboratory workflows and high-fidelity genomic discoveries. See how our specialized kits power the latest techniques in cancer research.

1. Single-Cell Proteogenomics & Ribosome Profiling (Ribo-seq)

The Research Frontier

Scientists are moving beyond traditional RNA sequencing to map the translational landscape of individual cancer cells. By analyzing ribosome-protected footprints (RPFs), researchers can identify hidden driver proteins, such as the ID1 protein in leukemia, at the level of a single cell.

The Laboratory Bottleneck

In single-cell analysis, the ultimate bottleneck is sample quantity. Standard extraction methods risk losing precious material because minute amounts of nucleic acid stick irreversibly to traditional matrices.

The MACHEREY-NAGEL Solution: NucleoSpin RNA Plus XS

• Maximum Recovery:
  Engineered with an "Extra Small" column layout optimized for ultra-low RNA inputs.
• Streamlined Workflow:
  Features an integrated gDNA removal column that strips genomic contamination instantly.
• Pure Results:
  Eliminates the need for time-consuming enzymatic treatment steps, protecting tiny RPF fragments from degradation.

Explore NucleoSpin RNA Plus XS

2. Spatial Transcriptomics: Preserving Tumor Microenvironments

The Research Frontier

Isolating tumor cells using harsh mechanical digestion strips them of their spatial coordinates. To understand how cancer cells interact with neighboring healthy cells, researchers now use spatial transcriptomics to create micro-coordinate maps of intact tissues.

The Laboratory Bottleneck

Spatial transcriptomics frequently relies on archival Formalin-Fixed Paraffin-Embedded (FFPE) tissue. Formalin creates tough protein crosslinks and degrades RNA over time, making it notoriously difficult to extract without losing structural integrity.

The MACHEREY-NAGEL Solution: Tailored Kits for FFPE and Automation

• NucleoSpin totalRNA FFPE:
  Employs a specialized lysis buffer designed to break down harsh formalin crosslinks, recovering highly fragmented spatial transcripts without losing vital mRNA fractions.
• NucleoMag DNA FFPE:
  Driven by advanced magnetic bead technology, this kit allows automated platforms like the NucleoMag X32 to isolate pure, DNA from the exact same precious tumor micro-punch.

Explore NucleoSpin totalRNA FFPE

Explore NucleoMag DNA FFPE

3. Circulating Tumor DNA (ctDNA) from Liquid Biopsies

The Research Frontier

Traditional tissue biopsies fail to capture the full spatial and temporal heterogeneity of evolving tumors. Advanced liquid biopsy techniques non-invasively track tumor progression, treatment resistance, and minimal residual disease by isolating cell-free DNA (cfDNA), which is shed from dying cancer cells directly into blood plasma.

The Laboratory Bottleneck

Target tumor fragments are highly fragmented and present at minuscule concentrations amid a vast sea of healthy background DNA. Standard isolation workflows often fail to capture these low-frequency mutations. Additionally, co-purified plasma proteins and chemical anticoagulants can completely stall the preparation of the NGS library and the digital PCR detection.

The MACHEREY-NAGEL Solution: Solution: Unrivaled Sensitivity for Low-Abundance Analytes

• NucleoSpin cfDNA XS:
  Optimized for ultra-low volume plasma samples to isolate highly fragmented tumor DNA while fully eliminating background matrix inhibitors.
• NucleoSnap cfDNA:
  Utilizes a unique column design that allows rapid vacuum processing of massive plasma volumes, delivering high-concentration, pure templates ready for deep sequencing.

Explore NucleoSpin cfDNA XS

Explore NucleoSpin cfDNA

4. Single-Cell Epigenetics (scATAC-seq & scCUT&Tag)

The Research Frontier

Tumor cells develop drug resistance by altering their epigenome, which consists of the structural switches that activate or deactivate genes. Using hyperactive enzymes like Tn5 transposase, researchers can cut open chromatin architecture to identify where exactly epigenetic resistance barriers are forming.

The Laboratory Bottleneck

Following enzymatic cleavage, the resulting library contains a highly chaotic mixture of mismatched fragment lengths, primer dimers, and residual enzyme traces. Achieving accurate next-generation sequencing data requires precise, flawless size selection and the absolute removal of downstream enzymatic inhibitors.

The MACHEREY-NAGEL Solution: NucleoMag NGS Clean-up and Size Select

• Precision Targeting:
  By tuning the volumetric ratio of our magnetic bead suspension, you can execute precise single- or double-sided size selections.
• Optimized Libraries:
  Easily isolates the exact mononucleosomal and multinucleosomal fragment ladders generated by ATAC-seq or CUT&Tag.
• Sequence-Ready:
  Completely strips away background primers and unbound enzymes, delivering a pristine library compatible with any Next-Generation Sequencing (NGS) platform.

Optimize Your NGS Library Preparation

Why Leading Oncology Labs Trust MACHEREY-NAGEL

For over a century, MACHEREY-NAGEL has been synonymous with filtration, extraction, and laboratory reliability. Our comprehensive portfolio of bioanalysis products is designed to provide you with reproducible, high-purity data for your cancer research, from the initial single-cell isolation to the final high-throughput sequencing.

Ready to elevate your oncology research?